Inicio › Linfoma folicular › Utah › Salt Lake City
Ensayos clínicos de Linfoma folicular en Salt Lake City, UT
13 estudios para Linfoma folicular buscan participantes en centros de Salt Lake City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
ReclutandoFase 3
- Huntsman Cancer Institute - Oncology Division, Salt Lake City
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
ReclutandoFase 3
- Huntsman Cancer Institute/University of Utah, Salt Lake City
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
ReclutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- Intermountain Healthcare, Salt Lake City
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
ReclutandoFase 3
- Research Site, Salt Lake City
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
ReclutandoFase 1
- Huntsman Cancer Institute/University of Utah, Salt Lake City
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ReclutandoFase 3
- Huntsman Cancer Insititute, University of Utah, Salt Lake City
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- Huntsman Cancer Institute, Salt Lake City
- Intermountain Healthcare, Salt Lake City
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
ReclutandoFase 2
- University of Utah, Salt Lake City
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
ReclutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
ReclutandoFase 1
- Huntsman Cancer Institute, University of Utah, Salt Lake City
A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
ReclutandoFase 1/2
- University of Utah, Salt Lake City
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Salt Lake City
Ensayos de Linfoma folicular en otras ciudades
- New York City, NY24 estudios
- Milwaukee, WI19 estudios
- Houston, TX18 estudios
- Nashville, TN18 estudios
- Boston, MA17 estudios
- Baldwin Park, CA16 estudios
- Seattle, WA15 estudios
- Durham, NC15 estudios
- Columbus, OH13 estudios
- San Antonio, TX12 estudios
- Philadelphia, PA12 estudios
- Chicago, IL12 estudios
Otros estudios en Salt Lake City
- Cáncer de pulmón de células no pequeñas31 estudios
- Cáncer de seno28 estudios
- Cáncer (todos los tipos)27 estudios
- Cáncer del colon y del recto22 estudios
- Melanoma21 estudios
- Mieloma múltiple21 estudios
- Cáncer de pulmón21 estudios
- Cáncer metastásico20 estudios
- Cáncer de ovario19 estudios
- Fallo cardíaco17 estudios
- Leucemia mielógena aguda17 estudios
- Obesidad16 estudios
De ClinicalTrials.gov, datos obtenidos el 7 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.